24 November 2017

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology makes the following update on its block listing, pursuant to AIM Rule 29 and Schedule Six of the AIM Rules for Companies. All figures relate to options over ordinary shares of 0.2 pence each.

The table below provides further detail.

Name of company: Futura Medical plc
Name of scheme: Unapproved Share Option Scheme ("USOS")

EMI Share Option Scheme ("EMI")
Period of return: From: 25 May 2017
To: 24 November 2017
Number and class of securities not issued under the scheme(s) at start of period USOS: 2,446,110
EMI: 3,021,390
Total: 5,467,500
Number of securities issued under the scheme(s) during the period
Number of securities lapsed under the scheme(s) during the period
USOS: -
EMI: -
USOS: 50,000
EMI: 350,000
Balance under the scheme(s) of securities not yet issued at the end of the period USOS: 2,396,110
EMI: 2,671,390
Total: 5,067,500
Number and class of securities originally admitted and the date of admission USOS: 814,424 on 25 May 2011,
1,202,280 on 8 October 2013,
1,466,208 on 25 May 2017
USOS Total: 3,482,912
   
EMI: 1,520,576 on 25 May 2011,
1,467,720 on 8 October 2013
1,893,792 on 25 May 2017
EMI Total: 4,882,088
   
  Total: 8,365,000
Name of contact: Derek Martin, Chief Financial Officer
Telephone number of contact: +44 (0) 1483 685 670

 

For further information please contact:

Futura Medical plc
James Barder, Chief Executive
+44 (0) 1483 685 670
james.barder@futuramedical.com
www.futuramedical.com

Nominated Adviser:
N+1 Singer
Aubrey Powell / Liz Yong / Thomas Smale
Tel: +44 (0) 20 7496 3000

For media enquiries please contact:

Buchanan Communications Limited
Mark Court / Sophie Cowles /
Stephanie Watson
Tel: +44 (0) 20 7466 5000

 

Notes to Editors

About Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com